Organizations that approach PACS migration as a data movement exercise tend to discover their interface dependencies during cutover, when the cost of discovery is highest. The HL7 interfaces connecting a PACS to the EHR/EMR, RIS, VNA, scheduling systems, reporting platforms, and downstream clinical tools are not automatically portable. They must be inventoried, evaluated, rebuilt or reconfigured, tested systematically, and monitored after go-live.
This article is a practical guide to that work. It covers the interface types involved, how to build a complete inventory, what testing should look like, how to handle cutover safely, and what to watch for in the weeks after go-live.
Why PACS migration always affects HL7 interfaces
A new PACS platform is almost never a drop-in replacement at the interface level. Even when the new vendor promises compatibility, the message configurations, queue identifiers, application IDs, segment mappings, and procedure code expectations differ from the prior system. The interface engine or integration platform that routes messages to the old PACS must be reconfigured to route to the new one, and that reconfiguration touches every connected interface.
Additional complexity arises when the migration includes a RIS replacement, a VNA deployment, or a consolidation of multiple imaging environments. Each of those changes multiplies the interface surface that must be evaluated and tested.
The interface types that connect to a PACS environment
A complete interface inventory for a PACS migration needs to account for every message type that crosses the boundary between the imaging environment and other clinical or operational systems.
| Message type | Purpose | Migration risk if not managed |
|---|---|---|
| ADT (A01, A04, A08, A40) | Patient registration, demographics, merges | Patient identity mismatches, rejected orders, orphaned studies |
| ORM / OMG | Imaging orders from EHR/EMR or RIS | Missing worklist items, wrong procedure codes, failed order routing |
| ORU | Results and reports delivered back to clinical systems | Missing results in EHR/EMR, broken report delivery, delayed clinical access |
| SIU | Scheduling notifications between RIS, EHR/EMR, and appointment systems | Scheduling data gaps, double-bookings, patient appointment confusion |
| MDM | Document management and transcription events | Missing transcription events, broken document workflows, report routing failures |
| DICOM MWL | Modality worklist providing patient and order context to scanners | Incorrect patient data populated at acquisition, manual data entry burden |
Building the interface inventory before migration begins
An accurate interface inventory is the foundation of migration interface planning. Without it, testing is incomplete, and cutover carries hidden dependencies that only surface when clinical workflows break.
A thorough inventory documents: the source and destination for each interface, the message type and event codes handled, the interface engine or integration platform routing the traffic, the criticality of the interface to clinical operations, and any known edge cases or workarounds that exist in the current configuration.
In many organizations, this inventory does not exist in current form. Interfaces have been added, modified, and forgotten over years. The migration process often becomes the first time anyone has a complete map of the integration surface. That discovery is valuable, but doing it under migration timeline pressure is not ideal.
Interface inventory work that gets deferred until the migration is underway adds risk to a project already carrying significant operational exposure. Starting the inventory early is almost always the right call.
Pre-migration testing for HL7 interfaces
Testing HL7 interfaces for a PACS migration requires a structured approach that goes beyond sending a few test messages. The test environment must reflect the real message patterns of the production environment, and the test cases must cover the full range of events that the imaging workflow encounters.
Critical test scenarios include: standard order-to-result workflows for each modality and specialty, demographic correction events (A08, A31) applied after an order is placed, patient merge events (A40) and how the new PACS handles them, order amendment scenarios where the original order changes after the study is already in progress, downtime order workflows for periods when the EHR/EMR is unavailable, and the specialty-specific order and result patterns for cardiology, radiation oncology, or any other service with non-standard workflow requirements.
Interfaces to external systems — referral networks, teleradiology platforms, remote reading vendors, and outpatient imaging centers — often receive less attention in pre-migration testing and are disproportionately represented in post-go-live issues.
Cutover planning for interface go-live
The cutover window for a PACS migration is when interface changes go live in production. This is the highest-risk phase of interface management. A few practices that reduce that risk:
- Define a go or no-go checklist for interface readiness that is separate from the data migration readiness checklist. Interface testing passing is a prerequisite, not an assumption.
- Sequence interface cutovers carefully. ADT and order interfaces typically need to be live before results interfaces. Getting the sequence wrong adds to the confusion during go-live.
- Staff the integration team through the go-live window, not just through the initial cutover moment. Most interface issues surface in the first 24 to 72 hours, not in the first hour.
- Have clear rollback criteria. Define what level of interface failure would trigger a rollback decision, and make sure the team knows that criteria before the go-live window opens.
Post-go-live monitoring and stabilization
The first two weeks after a PACS go-live are the highest-risk period for interface instability. Order volumes return to normal, specialty workflows that were not heavily exercised during testing begin running, and the edge cases that did not appear in test scripts start showing up in production queues.
Interface monitoring during this period should include: message volume trending by type to identify unexplained drops, acknowledgment and rejection rates for each interface, latency metrics to detect processing delays before they affect clinical workflows, and a dedicated exception queue review that is worked daily rather than on a reactive basis.
Organizations that invest in interface monitoring tooling before the migration rather than after have a meaningfully better post-go-live experience. Integration control planes with transport visibility, runtime truth, diagnostics, routing, and replay support, such as Flow Bridge Integration, reduce the manual effort required to maintain this monitoring posture.
Frequently asked questions
How long should parallel testing run before a PACS cutover?
For environments with standard interface volumes, two to three weeks of parallel testing is a reasonable minimum. For environments with high-volume order flows, multiple specialty integrations, or complex cardiology and radiation oncology configurations, four to six weeks provides better coverage. The goal is to exercise enough real message variety — including demographic corrections, order amendments, and merge events — to be confident the new configuration handles them correctly. Cutting the testing window short is one of the most common ways PACS migrations create post-go-live interface failures.
What are the most common post-go-live HL7 failures in PACS migrations?
Order routing failures (ORM messages pointing to incorrect queues or using wrong procedure code mappings) and result delivery failures (ORU messages not reaching downstream clinical systems) are the most frequent. Specialty interfaces — particularly cardiology CVIS connections and radiation oncology system integrations — are disproportionately represented in post-go-live failures because they are often under-tested during preparation. ADT demographic mismatches between the new PACS and the EHR/EMR are also common, particularly in environments that did not perform a thorough patient identity review before migration.
Should you rebuild HL7 interfaces for the new PACS or migrate existing configurations?
Both approaches have tradeoffs. Migrating existing configurations preserves known behavior but carries forward accumulated complexity, undocumented workarounds, and legacy mapping logic that may not suit the new system. Rebuilding from scratch produces cleaner configurations but requires thorough documentation of existing behavior before you can replicate it. A hybrid approach works well in practice: rebuild the standard interfaces cleanly, then evaluate specialty and edge-case interfaces individually before deciding whether to migrate or rebuild each one.
Viogenx supports PACS migration and HL7 interface planning
Viogenx works with healthcare organizations on PACS and VNA migration planning, HL7 interface inventory, testing strategy, cutover preparation, and post-go-live stabilization.
Explore PACS and VNA migration services